Skip to main content
logo
Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
10.84
+0.64 (6.27%)
At close: Jul 2, 2026, 4:00 PM EDT
10.85
+0.01 (0.09%)
After-hours: Jul 2, 2026, 7:57 PM EDT

Solid Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-191.78-174.33-124.7-96.02-85.98-72.19
Depreciation & Amortization
1.621.642.462.582.412.96
Stock-Based Compensation
18.7316.9110.527.637.5413.37
Other Adjustments
2.676.318.860.5-18.251.13
Change in Receivables
----0.11-0.11
Changes in Accounts Payable
0.77-1.092.21-0.76-5.251.21
Changes in Accrued Expenses
3.854.054.77-6.975.83-2.26
Changes in Unearned Revenue
-----8.08-12.64
Changes in Other Operating Activities
-10.93-9.78-4.12-1.143.7-9.25
Operating Cash Flow
-171.67-156.29-100.01-94.18-97.98-77.76
Capital Expenditures
-1.19-1.15-0.65-1.52-3.02-1.28
Sale of Property, Plant & Equipment
-0.090.01-0.6-
Purchases of Investments
-254.01-235.89-204.34-117.43-182.76-141.25
Proceeds from Sale of Investments
268.88178.5188.9128.63212.8151.44
Payments for Business Acquisitions
----31.52-
Other Investing Activities
0.04-----
Investing Cash Flow
13.77-58.45-16.099.6959.16-91.09
Long-Term Debt Issued
----2.14-
Long-Term Debt Repaid
-----0.07-
Net Long-Term Debt Issued (Repaid)
----2.08-
Issuance of Common Stock
241.87196.85128.023.1272.75134.99
Net Common Stock Issued (Repurchased)
241.87196.85128.023.1272.75134.99
Other Financing Activities
-15.14-2.4-5.58---
Financing Cash Flow
243.75194.45122.443.1274.83134.99
Net Cash Flow
85.84-20.36.34-81.3736.01-33.87
Free Cash Flow
-172.86-157.44-100.67-95.7-100.99-79.05
FCF Margin
-----1247.74%-580.36%
Free Cash Flow Per Share
-1.76-1.80-2.47-4.81-11.86-11.10
Levered Free Cash Flow
-197.66-180.66-120.05-103.82-88.31-93.44
Unlevered Free Cash Flow
-202.34-185.55-125.08-112.05-110.86-93.5
SEC Filings: 10-K · 10-Q